Quantitative SSTR-PET/CT: a potential tool for predicting everolimus response in neuroendoctine tumour patients
, , , , , , , und
12. Juni 2024
Über diesen Artikel
Artikel-Kategorie: Research Article
Online veröffentlicht: 12. Juni 2024
Seitenbereich: 348 - 356
Eingereicht: 12. März 2024
Akzeptiert: 10. Mai 2024
DOI: https://doi.org/10.2478/raon-2024-0032
Schlüsselwörter
© 2024 Homeira Karim et al., published by Sciendo
This work is licensed under the Creative Commons Attribution 4.0 International License.
Karim, Homeira
Department of Radiology, University Hospital, LMU MunichMunich, Germany
Winkelmann, Michael
Department of Radiology, University Hospital, LMU MunichMunich, Germany
Grawe, Freba
Department of Nuclear Medicine, University Hospital, LMU MunichMunich, Germany
Völter, Friederike
Department of Nuclear Medicine, University Hospital, LMU MunichMunich, Germany
Auernhammer, Christoph
ENETS Centre of Excellence, Interdisciplinary Center of Neuroendocrine Tumours of the GastroEnteroPancreatic System at the University Hospital of Munich (GEPNET-KUM), University Hospital of MunichMunich, Germany
Department of Internal Medicine 4, University Hospital, LMU MunichGermany
Rübenthaler, Johannes
Department of Radiology, University Hospital, LMU MunichMunich, Germany
ENETS Centre of Excellence, Interdisciplinary Center of Neuroendocrine Tumours of the GastroEnteroPancreatic System at the University Hospital of Munich (GEPNET-KUM), University Hospital of MunichMunich, Germany
Ricke, Jens
Department of Radiology, University Hospital, LMU MunichMunich, Germany
ENETS Centre of Excellence, Interdisciplinary Center of Neuroendocrine Tumours of the GastroEnteroPancreatic System at the University Hospital of Munich (GEPNET-KUM), University Hospital of MunichMunich, Germany
Ingenerf, Maria
Department of Radiology, University Hospital, LMU MunichMunich, Germany
Schmid-Tannwald, Christine
Department of Radiology, University Hospital, LMU MunichMunich, Germany
ENETS Centre of Excellence, Interdisciplinary Center of Neuroendocrine Tumours of the GastroEnteroPancreatic System at the University Hospital of Munich (GEPNET-KUM), University Hospital of MunichMunich, Germany